1. You are here:
  2. BioIndustry Association
  3. Member profile: Ochre Bio
Ochre-Bio-Logo-Gray-and-Orange-1200X1200-pixels-01-3.png

Ochre Bio

Drug Discovery

  • Funding stage: Series A
  • Technology type: Tech Bio
  • Oxford
Email
[email protected]
Website
https://www.ochre-bio.com
Membership category
Corporate

Hayakawa Building, Oxford Science Park, Oxford, OX4 4GB, United Kingdom

Ochre Bio at a glance

Ochre Bio develops RNA therapies for liver disease, using genomics, big data, and whole human livers kept alive outside the human body.

About Ochre Bio

Ochre Bio is a biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for important liver health challenges, from increasing donor liver supply to reducing cirrhosis complications. To learn more, please visit www.ochre-bio.com

Therapeutic area(s)

  • Genetics/Genomics
  • Platform Technology
  • Metabolic Disorders

Articles Ochre Bio has contributed to

13 January 2022

Guest blog: Ochre Bio - Love Your Liver Month

Love Your Liver is a national awareness month devoted to liver health awareness and giving people the key steps needed to keep their liver healthy. We spoke to Ochre Bio, a liver medicines company, to find out what they're up to in this space.

Blog